Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

835 public trials 210 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Recruiting

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

NCT07459634

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • Valkyrie Clinical Trials, Inc. Los Angeles, California, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Carolina Blood and Cancer Care Rock Hill, South Carolina, United States
View Trial Details
Recruiting

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

NCT07407933

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Site 1001 Washington D.C., District of Columbia, United States
  • Site 1004 Louisville, Kentucky, United States
  • Site 1005 Houston, Texas, United States
  • Site 1002 Fairfax, Virginia, United States
View all 38 locations
View Trial Details
Recruiting

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

NCT07625644

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +19 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Los Alamitos Hematology/Oncology Medical Group Glendale, California, United States
  • MemorialCare Todd Cancer Institute Long Beach, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
View all 62 locations
View Trial Details
Recruiting

Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)

NCT07778316

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Cancer and Hematology Centers of Western Michigan Grand Rapids, Michigan, United States
  • Shanghai Pulmonary Hospital Shanghai, China
  • University of Florida Health Cancer Center at Orlando Health Orlando, Florida, United States
  • Oncology Hematology West PC Omaha, Nebraska, United States
View Trial Details
Recruiting

Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

NCT07061535

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Disease Small Cell Lung Cancer, +11 more
Locations
  • Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China
  • Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science Jinan, Shandong, China
  • Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences Hangzhou, Zhejiang, China
  • First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
View Trial Details
Recruiting

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

NCT07472517

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer (ES-SCLC), +9 more
Locations
  • Infirmary Cancer Care Mobile, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Bioresearch Partner - Hialeah Hospital Hialeah, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 245 locations
View Trial Details
Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT04585750

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details
Recruiting

A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

NCT07325136

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Duke Cancer Institute Durham, North Carolina, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View all 13 locations
View Trial Details

Related conditions